Is Kamdhenu Venture overvalued or undervalued?

As of 4 November 2025, the valuation grade for Kamdhenu Venture has moved from very attractive to attractive. The company appears to be overvalued at its current price of 8.15, especially when considering its PE ratio of 43.13, which is significantly higher than the industry average. The EV to EBITDA ratio stands at 17.05, while the ROCE and ROE are relatively low at 6.21% and 4.02%, respectively, indicating inefficiencies in generating returns.
In comparison to its peers, Kamdhenu Venture's PE ratio is notably higher than that of Kansai Nerolac, which has a PE of 31.76, and Akzo Nobel, with a PE of 36.33. This suggests that Kamdhenu Venture may not justify its current valuation when compared to these competitors. Additionally, the stock has underperformed significantly over the past year, with a return of -64.87% compared to the Sensex's 5.94%, further reinforcing the notion that the stock is overvalued.